Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Cerny

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|May 25, 2002
Viral crosstalk: who gets to say what first?Andreas Cerny
Journal of Hepatology|September 19, 2009
Hepatitis C after simultaneous liver-kidney transplantationAndreas Cerny
Swiss Medical Weekly|December 25, 2015
Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically!Andreas Cerny
Therapeutische Umschau. Revue Therapeutique|August 5, 2017
Andreas Cerny
Chemical Research in Toxicology|May 19, 2021
Safety of mRNA-Based Vaccines for SARS CoV-2Beatrice Barda, Andreas Cerny
Reviews in Medical Virology|March 23, 2005
Hepatitis C virus and the immune system: a concise reviewChristel Gremion, Andreas Cerny
Reviews in Medical Virology|November 20, 2003
Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis CThomas Hügle, Andreas Cerny
Medizinische Klinik (Munich, Germany : 1983)|October 19, 2004
[70-year-old patient with convulsive syncope]Thomas Hügle, Claudio Städler, Andreas Cerny
Swiss Medical Weekly|March 25, 2019
Controlling HCV in Switzerland: running against the clockAndreas Cerny, Raoul Blindenbacher, Alberto Moriggia
Advances in Experimental Medicine and Biology|October 10, 2022
Automated Scoring of Sleep and Associated EventsPeter Anderer, Marco Ross, Andreas Cerny, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|May 25, 2002
Viral crosstalk: who gets to say what first?Andreas Cerny
Journal of Hepatology|September 19, 2009
Hepatitis C after simultaneous liver-kidney transplantationAndreas Cerny
Swiss Medical Weekly|December 25, 2015
Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically!Andreas Cerny
Therapeutische Umschau. Revue Therapeutique|August 5, 2017
Andreas Cerny
Chemical Research in Toxicology|May 19, 2021
Safety of mRNA-Based Vaccines for SARS CoV-2Beatrice Barda, Andreas Cerny
Reviews in Medical Virology|March 23, 2005
Hepatitis C virus and the immune system: a concise reviewChristel Gremion, Andreas Cerny
Reviews in Medical Virology|November 20, 2003
Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis CThomas Hügle, Andreas Cerny
Medizinische Klinik (Munich, Germany : 1983)|October 19, 2004
[70-year-old patient with convulsive syncope]Thomas Hügle, Claudio Städler, Andreas Cerny
Swiss Medical Weekly|March 25, 2019
Controlling HCV in Switzerland: running against the clockAndreas Cerny, Raoul Blindenbacher, Alberto Moriggia
Advances in Experimental Medicine and Biology|October 10, 2022
Automated Scoring of Sleep and Associated EventsPeter Anderer, Marco Ross, Andreas Cerny, et al.
Pageof 10